QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.127027v1 323/1/94    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Schiel, M. A. Articles by Sanghani, S. P. Search for Related Content PubMed PubMed Citation Articles by Schiel, M. A. Articles by Sanghani, S. P.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Expression and Characterization of a Human Carboxylesterase 2 Splice Variant

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana

CPT-11 [7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin or Irinotecan] is a carbamate prodrug that is activated in vivo by carboxylesterase (CES)-2 to SN-38 (7-ethyl-10-hydroxycamptothecin), a potent topoisomerase I inhibitor. There is high interindividual variation when CPT-11 is used in the treatment of colorectal cancer. Several splice variants of CES2 are reported in the expressed sequence tag database. Real-time polymerase chain reaction was used to determine the abundance of the CES2 and splice variant of human carboxylesterase 2 (CES2^458–473) transcripts in 10 paired samples of human tumor and normal colon tissue. The results showed that the CES2^458–473 transcript accounts for an average of 6% of total CES2 transcripts in colon tissue, and there is large interindividual variation in CES2 expression in both tumor and normal colon samples. The carboxylesterase activity of the colon samples was determined by 4-methylumbelliferyl acetate hydrolysis assays and nondenaturing polyacrylamide gel electrophoresis followed by activity staining. Significant, positive correlations were found between CES2 expression levels and both measures of carboxylesterase activity. We cloned and expressed the CES2^458–473 protein in Sf9 insect cells. The purification profiles and preliminary characterization of the CES2^458–473 protein indicated that the expressed protein is folded and glycosylated like CES2. However, in vitro assays show that the CES2^458–473 protein lacks 4-methylumbelliferyl acetate and irinotecan hydrolase activities. In conclusion, we found that the CES2^458–473 protein is an inactive splice variant of CES2 and that its transcript is spliced at a relatively constant rate in tumor and normal colon tissue.

Address correspondence to: Sonal P. Sanghani, 1345 West 16th Street, Indianapolis, IN 46202. E-mail: ssanghan{at}iupui.edu